I often recommend looking for supplements that include Astaxanthin
Resuming treatment after interruption carries its own risks , particularly recurrence of dose-dependent side effects
July 18, 2025: Chinese Obesity Drug Outperforms Zepbound in Helping Patients Lose Weight, Trials Show A new obesity drug, HRS9531, made by the Chinese company Hengrui Pharma may help patients lose more weight than when on Zepbound
At Sakinah Health, we offer both time-tested and cutting-edge medications tailored to your health, history, and goals
This review underscores the importance of comprehending GLP-1s cardiovascular impact in diabetes, especially considering its increasing use in patients, discussing both risk factor mitigation and direct cardiac and vascular effects, and exploring GLP-1s potential as a novel therapy for diabetic CVD
Gwinn-Hardy, K